Bavarian Nordic accelererer produktionen af mpox-vaccinen Jynneos! Læs hvordan Danmark mestrer vaccineproduktion!
Bavarian Nordic, den danske bioteknologiske stjerne, har sat farten op for produktionen af deres mpox-vaccine, Jynneos. Beslutningen kommer efter en erklæring fra Verdenssundhedsorganisationen (WHO) om, at mpox udgør en global sundhedstrussel. Med en plan om at levere hele 12 millioner vacciner til Afrika, vil de første to millioner doser være klar i år for at imødegå det voksende udbrud. Det danske selskab er virkelig på forkant, når det kommer til at tackle udfordringer i sundhedsvæsenet!
For dem, der ikke er bekendte med mpox, kan det være en god idé at spolere dit natbord og hente forklaringerne! Tidligere kendt som monkeypox, er denne virus ikke sjov at lege med, og den har vist sig at sprede sig hurtigere end en viral TikTok-dans. Bavarian Nordic forbereder sig på at kunne producere ikke mindre end 10 millioner doser af deres vaccine inden 2025, hvilket er en lovende nyhed for både Danmark og verden.
I en tid, hvor lande kæmper for at stockpille medicinske forsyninger til fremtidige pandemier, er Bavarian Nordic ikke kun en udbyder, men også en innovatør. De har også indsendt en anmodning til det europæiske lægemiddelagentur (EMA) om at udvide anvendelsen af deres Imvanex-vaccine til unge, baseret på lovende resultater fra nylige studier. Det ser ud til, at danske foresight virkelig betaler sig!
Mens aktierne i Bavarian Nordic har lidt et lille dyk, så holder virksomheden stadig kursen. Der er evner inden for pharma-feltet, som Danmark er stolte af, og denne vaccineproduktion er blot en del af det eventyr. Med sit partnerskab med Africa CDC, er de også på arbejde for at booste lokale vaccineproduktionsmuligheder i Afrika.
Vidste du, at Jynneos er designet til at beskytte mod begge former for mpox, hvilket gør den til en dobbelttrussel mod viruset? Desuden, mens Bavarian Nordic sender vacciner til Afrika, er det en påmindelse om, hvordan internationalt samarbejde kan spille en central rolle i bekæmpelsen af globale sundhedskrisers. Danmark kan stå stolt som en del af denne fortælling – det er ikke kun hygge og smørrebrød, men også konstant innovation i kampen mod sygdomme!
The Danish company on Saturday announced plans to increase production of its vaccine Jynneos on the heels of the World Health Organization last week ...
After the WHO declared mpox a global health emergency, Bavarian Nordic said it could supply 2 million doses this year to contain the virus in Africa.
Amid the current mpox outbreak, Bavarian Nordic says it will have the capacity to manufacture 10 million doses of its vaccine by the end of 2025.
The EMA submission is based on a NIH study showing that MVA-BN vaccine responses and safety in adolescents are comparable to adults after two standard doses.
... ** Shares in Danish biotech Bavarian Nordic BAVA.CO fall about 3% at 0850 GMT, set to break a nine-day winning streak, if the trend continues.
After the World Health Organization this week warned that a fast-spreading strain of mpox poses a global threat, Denmark has a potential solution and ...
Denmark-based Bavarian Nordic to increase mpox vaccine production after WHO's declaration of global health emergency for new strain, clade 1b.
The company will ramp up manufacturing of its Jynneos vaccine to meet demand in worst-affected African countries and stockpiling richer nations.
Bavarian Nordic, a key player in vaccine production in Denmark, partnered with Africa CDC to boost local vaccine manufacturing capabilities.
Bavarian Nordic is working to get their MVA-BN (Jynneos) mpox vaccine to those affected in African countries, as well as working towards a clinical trial ...
Amid a new strain of mpox, the Danish company is preparing to make millions of vaccine doses to supply to the world.
Danish biotech firm Bavarian Nordic is considering ramping up production of its mpox vaccine without having orders lined up, based on talks this week with ...
Bavarian Nordic considers boosting production of its mpox vaccine as the disease spreads, awaiting firm contracts for manufacturing. Read more here.
LONDON (Reuters) -Danish biotech firm Bavarian Nordic could ramp up production of its mpox vaccine even before having orders lined up, based on the outcome ...
The Africa Centres for Disease Control and Prevention (Africa CDC) is in talks with Bavarian Nordic, the only global producer of an mpox vaccine, about.
The Danish company Bavarian Nordic plans to supply up to 2 million vaccine doses this year in response to the World Health Organization's declaration of ...